Skip to main content
Top

Current Colorectal Cancer Reports

Issue 6/2017

Content (8 Articles)

Systemic Therapies in Colorectal Cancer (RD Kim, Section Editor)

Second-Line Therapy for Advanced Colorectal Cancer: EGFR vs. Continuation of VEGF Inhibition

Michael T. Serzan, Benjamin A. Weinberg, Mohamed E. Salem

Systemic Therapies in Colorectal Cancer (RD Kim, Section Editor)

Conversion Therapy for Initially Borderline/Unresectable Metastases in Colon Cancer: What Is the Best Neoadjuvant Chemotherapy?

Sigurdis Haraldsdottir, Richard M. Goldberg

Nutrition and Nutritional Interventions in Colorectal Cancer (K Wu, Section Editor)

Diet, Gut Microbiota, and Colorectal Cancer Prevention: a Review of Potential Mechanisms and Promising Targets for Future Research

Mingyang Song, Andrew T. Chan

Nutrition and Nutritional Interventions in Colorectal Cancer (K Wu, Section Editor)

Dietary Patterns and Colorectal Cancer Risk: a Review of 17 Years of Evidence (2000–2016)

Fred K. Tabung, Lisa S. Brown, Teresa T. Fung

Open Access NUTRITION AND NUTRITIONAL INTERVENTIONS IN COLORECTAL CANCER (K WU, SECTION EDITOR)

Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology

Laura A. E. Hughes, Colinda C. J. M. Simons, Piet A. van den Brandt, Manon van Engeland, Matty P. Weijenberg

Diagnostic and Interventional Radiology Innovations in Colorectal Cancer (G de Prisco, Section Editor)

Liver Imaging for Colorectal Cancer Metastases

Daniel R. Ludwig, Aaron J. Mintz, Vanessa R. Sanders, Kathryn J. Fowler

Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer (N Kubiliun, Section Editor)

Stool- and Blood-Based Molecular Tests in Screening for Colorectal Cancer: Ready for Prime Time?

Chung Wah Wu, Joseph Jao-Yiu Sung

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine